Run PREDICT and Guardian against your actual claims and eligibility data. We surface the high-cost surgical cohort sitting in your plan today, route the willing through our credential-verified network, and stand behind it with a contractual no-savings-no-bill guarantee. The four-page term sheet ships with this page so your fiduciary committee can review it on day one.
Procedure scope is large enough to surface real signal, narrow enough to keep clinical safety unambiguous.
Geographies: Mexico, Colombia, Costa Rica, Panama, Brazil, Thailand, Turkey, Singapore, South Korea, Spain, Czech Republic. Full network list in the term sheet.
A clinical-eligibility screen runs before every outreach. Members who don't pass are returned to the plan's incumbent network with no penalty and no record of the decline.
The pilot converts to a paid contract if any one of these is met inside the window. If none are met, JetPatient absorbs every cost and the plan owes nothing.
Measured vs. the plan's incumbent in-network allowed for the same procedure family.
PREDICT identifies, Guardian outreach reaches them, even if no surgery converts inside the window.
Measured at post-discharge and again at 90 days. We hold ourselves to the higher bar.
Validates the integration path — eligibility ingest, claims tokenization, PREDICT scoring end-to-end.
No PEPM. No implementation fee. Conversion pricing is capped per case so the plan's stop-loss-leveling benefit accrues to the plan, not us.
We're plan-agnostic. We hold a HIPAA BAA with every sub-processor before any data moves.
The term sheet covers scope, success, pricing, data, IP, and exit on a single document. The model card and compliance attestation give your committee the safety and governance story without a sales call.
Every routed case carries a JetPatient post-op safety net: 24×7 coordinator, in-country re-admission coverage at the original facility, telemedicine with the operating surgeon for 90 days, and a documented hand-off to the member's US primary care doctor. If a complication requires US re-admission within 90 days, JetPatient covers the difference between the plan's allowed and the actual incurred — capped at the original procedure's domestic equivalent.
The pilot is structurally invisible to stop-loss: routed cases reduce the spec and aggregate attachment exposure (lower claims = lower utilization) but don't change contract terms. Most carriers (Sun Life, Tokio Marine HCC, Symetra, BCS, Berkshire, ELMC) have a formal medical-tourism rider; we'll provide attestation letters on request and engage your carrier directly during pilot setup if helpful.
Yes. Eligibility ingest covers the entire census including dependents. PREDICT scores the member and Guardian's outreach respects the plan's dependent-coverage rules (subscriber vs. dependent permission, age cut-offs, special-needs flags). Pediatric procedures and pregnancy-related care are excluded from the pilot.
No. JetPatient sits next to the TPA, not on top of it. The TPA continues to administer the plan; JetPatient receives a tokenized eligibility and claims feed and returns scored cohorts and outreach status. We've integrated with WebTPA, Trustmark, Healthcomp, EBMS, and Luminare patterns; the integration spec is on the For TPAs page.
JetPatient holds no discretionary authority over plan administration and takes no provider-side payment tied to plan referrals. The Model Card, Validation Pack, and quarterly Fairness Audit Log are the standard artifacts a fiduciary committee can place in plan committee minutes to evidence prudent-process review under ERISA §404(a)(1)(B). An attorney-reviewed one-pager is available on request.
The pilot's pipeline threshold (Threshold 2) is the protection here: if PREDICT scores fewer than 25 top-decile members in your population, the pilot still meets success on Threshold 4 (operational — first scored cohort in 21 days) and we'll extend the pilot at no additional cost for an additional 90 days to gather a fuller longitudinal window.
PREDICT v0.1 is a working pipeline trained on simulated cohorts and is not approved for production use. The headline metrics (89% precision, $2.4M modeled savings, 14-month lead time) are v1.0 target spec, validated against the simulated test set. First real-world readout is targeted Q3 2026. The full Model Card explains this honestly and is downloadable above. We disclose this proactively in every term sheet.
Email partnerships@jetpatient.com with your plan name, covered-life count, and incumbent TPA + stop-loss carrier. A Benefits Strategist responds within one business day with a tailored MSA + BAA package and a proposed 14-day kickoff plan.